CenterBook Partners LP increased its holdings in shares of Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO) by 570.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 80,278 shares of the basic materials company’s stock after acquiring an additional 68,306 shares during the period. CenterBook Partners LP’s holdings in Cameco were worth $6,958,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of CCJ. Wellington Management Group LLP acquired a new position in Cameco in the second quarter worth $212,908,000. Amundi grew its holdings in shares of Cameco by 13.7% during the second quarter. Amundi now owns 2,992,074 shares of the basic materials company’s stock worth $304,773,000 after purchasing an additional 359,375 shares during the last quarter. Temasek Holdings Private Ltd acquired a new stake in shares of Cameco in the first quarter valued at $70,851,000. Sumitomo Mitsui Trust Group Inc. increased its stake in shares of Cameco by 35.2% in the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 535,743 shares of the basic materials company’s stock valued at $58,187,000 after buying an additional 139,592 shares in the last quarter. Finally, Bank of America Corp DE acquired a new stake in shares of Cameco in the second quarter valued at $735,498,000. 70.21% of the stock is owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
CCJ has been the topic of several research reports. Weiss Ratings upgraded shares of Cameco from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, October 8th. Citigroup reissued a “positive” rating on shares of Cameco in a report on Wednesday, July 15th. Barclays lowered their price objective on shares of Cameco from $95.00 to $89.00 and set an “equal weight” rating for the company in a research report on Monday, November 2nd. Zacks Research raised shares of Cameco from a “strong sell” rating to a “hold” rating in a research note on Tuesday. Finally, Jefferies Financial Group began coverage on shares of Cameco in a research report on Thursday, September 3rd. They set a “buy” rating and a $138.00 target price on the stock. Eleven analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. Based on data from MarketBeat, Cameco currently has an average rating of “Moderate Buy” and an average target price of $147.38.
View Our Latest Research Report on CCJ
Cameco Trading Up 4.4%
Shares of NYSE CCJ traded up $3.01 during midday trading on Friday, hitting $71.34. The stock had a trading volume of 5,333,852 shares, compared to its average volume of 3,651,351. The firm has a market cap of $31.07 billion, a P/E ratio of 108.09, a price-to-earnings-growth ratio of 1.56 and a beta of 1.18. Cameco Corporation has a fifty-two week low of $66.06 and a fifty-two week high of $135.24. The company has a debt-to-equity ratio of 0.14, a current ratio of 2.55 and a quick ratio of 2.10. The company’s 50-day simple moving average is $87.26 and its 200 day simple moving average is $103.15.
Cameco Announces Dividend
The company also recently disclosed an annual dividend, which will be paid on Tuesday, December 15th. Investors of record on Monday, November 30th will be given a C$0.24 dividend. This represents a yield of 22.0%. The ex-dividend date is Monday, November 30th. Cameco’s dividend payout ratio (DPR) is presently 25.76%.
Cameco News Roundup
Here are the key news stories impacting Cameco this week:
- Positive Sentiment: Investors bought 152,544 call options on Friday—nearly five times the average daily volume. This suggests increased bullish positioning, though options activity does not guarantee a stock move.
- Positive Sentiment: Zacks Research upgraded Cameco from “strong sell” to “hold,” a modest improvement in analyst sentiment.
- Neutral Sentiment: Management highlighted disciplined uranium pricing, tight nuclear-fuel supplies and Westinghouse growth opportunities on its Q3 earnings call, but also acknowledged higher costs and weaker quarterly earnings. Cameco Q3 Earnings Call Highlights Uranium Pricing Discipline
- Negative Sentiment: Scotiabank cut its FY2026 EPS forecast to $0.64 from $0.85 and FY2027 to $1.29 from $1.44, adding pressure to the earnings outlook.
- Negative Sentiment: Cameco renewed its at-the-market equity program, which gives it the option to sell shares and raise capital but could dilute existing shareholders if used. Cameco Reports Document Filing
- Negative Sentiment: A recent earnings analysis points to a gap between an approximately $89 market uranium price and Cameco’s roughly $66 selling price, a factor that may delay the benefit of stronger spot prices flowing through to results. Cameco Earnings Analysis
Cameco Profile
Further Reading
- Five stocks we like better than Cameco
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
- Airbnb Defied a Brutal Tech Sell-Off, But Can Its Post-Earnings Rally Last?
Want to see what other hedge funds are holding CCJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cameco Corporation (NYSE:CCJ – Free Report) (TSE:CCO).
Receive News & Ratings for Cameco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cameco and related companies with MarketBeat.com's FREE daily email newsletter.
